CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 21 enrolled
Drug / intervention
Lidoderm patch +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00686127
NCT00686127Phase 4Completed
CompareCT.gov

A Randomized, Double-Blind, Placebo-Controlled Trial (RDBPCT) of the Effectiveness of the Lidocaine Patch in the Management of Neuropathic Pain After Breast Cancer Surgery

University of California, San Francisco·interventional·Posted May 29, 2008·Updated Jun 28, 2018

In Brief

A Phase 4 clinical trial evaluating Lidoderm patch and Placebo patch for Neuropathic Pain and Postmastectomy Pain. Completed, enrolled 21 participants across 1 site.

Detailed Summary

This trial is part of a larger, longitudinal study of symptoms that occur in the breast surgical scar area and/or ipsilateral arm following breast cancer surgery. Women who develop pain in the breast scar area or ipsilateral arm will be randomized to a placebo patch or a lidocaine patch that they will wear on a daily basis for 12 weeks. We hypothesize that women who wear the lidocaine patch will report a decrease in pain and decreased interference with function compared to women who wear the placebo patch.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeuropathic Pain, Postmastectomy Pain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 29, 2008
Enrollment StartSep 1, 2003
Primary CompletionDec 1, 2007
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 18.1 years ago

Interventions

Lidoderm patchdrug

1 patch was applied topically to the affected site(s) for 12 hours each day.

Placebo patchdrug

1 patch was applied topically to the affected site(s) for 12 hours each day.